Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.
about
Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report.Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studiesPrediction of chemotherapeutic efficacy using the ratio of neutrophils to lymphocytes in patients with unresectable or recurrent gastric cancerThe pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.
P2860
Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Diabetes mellitus and the neut ...... ansarterial chemoembolization.
@en
type
label
Diabetes mellitus and the neut ...... ansarterial chemoembolization.
@en
prefLabel
Diabetes mellitus and the neut ...... ansarterial chemoembolization.
@en
P2093
P2860
P356
P1433
P1476
Diabetes mellitus and the neut ...... ansarterial chemoembolization.
@en
P2093
Fengyun Gong
Jiangguo Zhang
Manzhi Zhao
P2860
P304
P356
10.3892/OL.2014.1896
P50
P577
2014-02-20T00:00:00Z